Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events

Theodore Wein; M Patrice Lindsay; David J Gladstone; Alexandre Poppe; Alan Bell; Leanne K Casaubon; Norine Foley; Shelagh B Coutts; Jafna Cox; James Douketis; Thalia Field; Laura Gioia; Jeffrey Habert; Eddy Lang; Shamir R Mehta; Christine Papoushek; William Semchuk; Mikul Sharma; Jacob A Udell; Stephanie Lawrence; Anita Mountain; Gord Gubitz; Dar Dowlatshahi; Anne Simard; Andrea de Jong; Eric E Smith; Heart and Stroke Foundation of Canada in collaboration with the Canadian Stroke Consortium

doi:10.1503/cmaj.191599

Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events

CMAJ. 2020 Mar 23;192(12):E302-E311. doi: 10.1503/cmaj.191599.

Authors

Theodore Wein¹, M Patrice Lindsay², David J Gladstone¹, Alexandre Poppe¹, Alan Bell¹, Leanne K Casaubon¹, Norine Foley¹, Shelagh B Coutts¹, Jafna Cox¹, James Douketis¹, Thalia Field¹, Laura Gioia¹, Jeffrey Habert¹, Eddy Lang¹, Shamir R Mehta¹, Christine Papoushek¹, William Semchuk¹, Mikul Sharma¹, Jacob A Udell¹, Stephanie Lawrence¹, Anita Mountain¹, Gord Gubitz¹, Dar Dowlatshahi¹, Anne Simard¹, Andrea de Jong¹, Eric E Smith¹; Heart and Stroke Foundation of Canada in collaboration with the Canadian Stroke Consortium

Affiliations

¹ Department of Neurology and Neurosurgery (Wein), McGill University, Montréal, Que.; the Heart and Stroke Foundation of Canada (Lindsay, Lawrence, Simard, de Jong); Division of Neurology (Gladstone, Casaubon), Department of Medicine, University of Toronto; Division of Neurology (Gladstone), Department of Medicine, Regional Stroke Centre; Hurvitz Brain Sciences Program (Gladstone), Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (Gladstone); Toronto, Ont.; Centre hospitalier de l'Université de Montréal (CHUM) (Poppe, Gioia), Hôpital Notre-Dame, Montréal, Que.; Department of Family Medicine (Bell, Habert), University of Toronto; Toronto Western Hospital Stroke Program (Casaubon), University Health Network, Toronto, Ont.; workHORSE Consulting Ltd. (Foley), London, Ont.; Department of Clinical Neurosciences (Coutts, Smith), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Faculty of Medicine (Cardiology) (Cox), Dalhousie University, Halifax, NS; Department of Medicine (Douketis), McMaster University, Hamilton, Ont.; Division of Neurology (Field), Department of Medicine, University of British Columbia; Vancouver, BC; Department of Emergency Medicine (Lang), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cardiology (Mehta), Department of Medicine, McMaster University, Hamilton, Ont.; Department of Family and Community Medicine (Papoushek), Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ont.; College of Pharmacy (Semchuk), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology (Sharma), Department of Medicine, McMaster University, Hamilton, Ont.; Cardiovascular Division (Udell), Department of Medicine Women's College Hospital; Peter Munk Cardiac Centre (Udell), Toronto General Hospital, University of Toronto, Toronto, Ont.; Divisions Physical Medicine and Rehabilitation) (Mountain) and Neurology (Gubitz), Department of Medicine, Dalhousie University; Division of Neurology (Dowlatshahi), Faculty of Medicine, University of Ottawa, Ottawa, Ont.
² Department of Neurology and Neurosurgery (Wein), McGill University, Montréal, Que.; the Heart and Stroke Foundation of Canada (Lindsay, Lawrence, Simard, de Jong); Division of Neurology (Gladstone, Casaubon), Department of Medicine, University of Toronto; Division of Neurology (Gladstone), Department of Medicine, Regional Stroke Centre; Hurvitz Brain Sciences Program (Gladstone), Sunnybrook Health Sciences Centre; Sunnybrook Research Institute (Gladstone); Toronto, Ont.; Centre hospitalier de l'Université de Montréal (CHUM) (Poppe, Gioia), Hôpital Notre-Dame, Montréal, Que.; Department of Family Medicine (Bell, Habert), University of Toronto; Toronto Western Hospital Stroke Program (Casaubon), University Health Network, Toronto, Ont.; workHORSE Consulting Ltd. (Foley), London, Ont.; Department of Clinical Neurosciences (Coutts, Smith), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Faculty of Medicine (Cardiology) (Cox), Dalhousie University, Halifax, NS; Department of Medicine (Douketis), McMaster University, Hamilton, Ont.; Division of Neurology (Field), Department of Medicine, University of British Columbia; Vancouver, BC; Department of Emergency Medicine (Lang), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cardiology (Mehta), Department of Medicine, McMaster University, Hamilton, Ont.; Department of Family and Community Medicine (Papoushek), Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ont.; College of Pharmacy (Semchuk), University of Saskatchewan, Saskatoon, Sask.; Division of Neurology (Sharma), Department of Medicine, McMaster University, Hamilton, Ont.; Cardiovascular Division (Udell), Department of Medicine Women's College Hospital; Peter Munk Cardiac Centre (Udell), Toronto General Hospital, University of Toronto, Toronto, Ont.; Divisions Physical Medicine and Rehabilitation) (Mountain) and Neurology (Gubitz), Department of Medicine, Dalhousie University; Division of Neurology (Dowlatshahi), Faculty of Medicine, University of Ottawa, Ottawa, Ont. patrice.lindsay@heartandstroke.ca.

No abstract available

Publication types

Practice Guideline

MeSH terms

Aspirin / therapeutic use*
Canada
Cardiovascular Diseases / prevention & control*
Decision Making, Shared
Humans
Primary Prevention
Risk Assessment
Secondary Prevention*
Stroke / prevention & control*

Substances

Aspirin